US2019046544A1PendingUtilityA1
Omega-3 compositions
Assignee: AKER BIOMARINE ANTARCTIC ASPriority: Sep 24, 2012Filed: Oct 19, 2018Published: Feb 14, 2019
Est. expirySep 24, 2032(~6.2 yrs left)· nominal 20-yr term from priority
A61P 9/00A61K 9/4858A61P 25/24A61P 25/28A61K 31/685
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to compositions comprising omega-3 fatty acid derivatives, and in particular to compositions comprising omega-3 phospholipids in combination with other omega-3 derivatives.
Claims
exact text as granted — not AI-modified1 . A composition comprising a mixture of phospholipid compounds having the following structure:
wherein R1 and R2 are selected from the group consisting of a fatty acid moiety and H and R3 is H or a choline, ethanolamine, inositol and serine moiety, said mixture of phospholipid compounds comprising more than about 90% choline moieties at position R3 and more than about 30% w/w omega-3 fatty acid moieties, wherein more than about 90% w/w of said omega-3 fatty acid moieties are at position R2,
and
a mixture of omega-3 fatty acid derivatives selected from the group consisting of:
a mixture of glyceride compounds having the following structure:
wherein at least one of either R1, R2, and R3 is a an omega-3 fatty acid moiety, and the other two of either R1, R2 and R3 may H or a fatty acid moiety, and
esters and free fatty acids of omega-3 fatty acids, and combinations thereof.
2 . The composition of claim 1 , wherein said mixture of omega-3 fatty acid derivatives comprises at least 30% omega-3 fatty acid moieties on a w/w basis.
3 . The composition of claim 1 , wherein said mixture of omega-3 fatty acid derivatives comprises at least 50% omega-3 fatty acid moieties on a w/w basis.
4 . The composition of claim 1 , wherein said mixture of omega-3 fatty acid derivatives comprises at least 65% omega-3 fatty acid moieties on a w/w basis.
5 . The composition of claim 1 , wherein said composition comprises at least 80% omega-3 fatty acid moieties on a w/w basis.
6 . The composition of claim 1 , wherein said omega-3 fatty acid moieties are selected from the group consisting of eicosapentaenoic acid, docosahexaenoic acid, and combinations thereof.
7 . The composition of claim 1 , wherein said composition comprises at least 5% w/w of said phospholipid compounds.
8 . The composition of claim 1 , wherein said composition comprises at least 25% w/w of said phospholipid compounds.
9 . The composition of claim 1 , wherein said composition comprises at least 50% w/w of said phospholipid compounds.
10 . The composition of claim 1 , wherein said composition comprises at least 70% w/w of said phospholipid compounds.
11 . The composition of claim 7 , wherein said omega-3 moieties in said mixture of mixture of phospholipid compounds are eicosapentaenoic acid and said docosahexaenoic acid and wherein said eicosapentaenoic acid and said docosahexaenoic acid are present in a ratio of eicosapentaenoic acid:docosahexaenoic acid of from about 1:1 to about 3:1.
12 . The composition of claim 7 , wherein said composition comprises at least 10% ethyl esters comprising said omega-3 fatty acid moieties.
13 . The composition of claim 7 , wherein said composition comprises at least 20% ethyl esters comprising said omega-3 fatty acid moieties.
14 . The composition of claim 7 , wherein said composition comprises at least 30% ethyl esters comprising said omega-3 fatty acid moieties.
15 . The composition of claim 7 , wherein said composition comprises at least 50% ethyl esters comprising said omega-3 fatty acid moieties.
16 . The composition of claim 7 , wherein said composition comprises at least 70% ethyl esters comprising said omega-3 fatty acid moieties.
17 . The composition of claim 7 , wherein said composition comprises at least 90% ethyl esters comprising said omega-3 fatty acid moieties.
18 . The composition of claim 7 , wherein said composition comprises at least 10% glyceride compounds comprising said omega-3 fatty acid moieties.
19 . The composition of claim 7 , wherein said composition comprises at least 30% glyceride compounds comprising said omega-3 fatty acid moieties.
20 . The composition of claim 7 , wherein said composition comprises at least 50% glyceride compounds comprising said omega-3 fatty acid moieties.
21 . The composition of claim 7 , wherein said composition comprises at least 70% glyceride compounds comprising said omega-3 fatty acid moieties.
22 . The composition of claim 7 , wherein said composition comprises at least 90% glyceride compounds comprising said omega-3 fatty acid moieties.
23 . The composition of any of claim 7 , wherein said composition comprises at least 10% omega-3 free fatty acids.
24 . The composition of claim 7 , wherein said composition comprises at least 30% omega-3 free fatty acids.
25 . The composition of claim 7 , wherein said composition comprises at least 50% omega-3 free fatty acids.
26 . The composition of claim 7 , wherein said composition comprises at least 70% omega-3 free fatty acids.
27 . The composition of claim 7 , wherein said composition comprises at least 90% omega-3 free fatty acids.
28 . The composition of claim 7 , wherein said omega-3 fatty acid moieties or free fatty acids are selected from the group consisting of eicosapentaenoic acid and docosahexaenoic acid and combinations thereof.
29 . The composition of claim 28 , wherein said eicosapentaenoic acid and said docosahexaenoic acid are present in a ratio of eicosapentaenoic acid:docosahexaenoic acid of from about 1:1 to about 3:1.
30 . The composition of claim 1 , wherein said composition comprises astaxanthin.
31 . The composition of claim 1 , wherein said composition comprises at least a second antioxidant.
32 . The composition of claim 1 , wherein said composition is partially or totally derived from krill.
33 . The composition of claim 1 , wherein said composition is provided in a formulation selected from the group consisting of a capsule, a tablet, a liquid, a powder, an emulsion, a dietary supplement, a nutritional supplement, a beverage and a functional food.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.